{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T14:52:42Z","timestamp":1784386362514,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T00:00:00Z","timestamp":1670716800000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016060","name":"Stichting De Cock-Hadders","doi-asserted-by":"publisher","award":["2022-81"],"award-info":[{"award-number":["2022-81"]}],"id":[{"id":"10.13039\/100016060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016060","name":"Stichting De Cock-Hadders","doi-asserted-by":"publisher","award":["2022-81"],"award-info":[{"award-number":["2022-81"]}],"id":[{"id":"10.13039\/100016060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016060","name":"Stichting De Cock-Hadders","doi-asserted-by":"publisher","award":["2022-81"],"award-info":[{"award-number":["2022-81"]}],"id":[{"id":"10.13039\/100016060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001721","name":"Rijksuniversiteit Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Dystonia is a rare movement disorder, in which patients suffer from involuntary twisting movements or abnormal posturing. Next to these motor symptoms, patients have a high prevalence of psychiatric comorbidity, suggesting a role for serotonin in its pathophysiology. This study investigates the percentage of DNA methylation of the gene encoding for the serotonin reuptake transporter (<jats:italic>SLC6A4)<\/jats:italic> in dystonia patients and the associations between methylation levels and presence and severity of psychiatric symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients with cervical dystonia (<jats:italic>n<\/jats:italic>\u2009=\u200949), myoclonus dystonia (<jats:italic>n<\/jats:italic>\u2009=\u200941) and dopa-responsive dystonia (DRD) (<jats:italic>n<\/jats:italic>\u2009=\u200927) and a group of healthy controls (<jats:italic>n<\/jats:italic>\u2009=\u200956) were included. Psychiatric comorbidity was evaluated with validated questionnaires. Methylation levels of 20 CpG sites situated 69 to 213 base pairs upstream of the start codon of <jats:italic>SLC6A4<\/jats:italic> were investigated. Methylation in dystonia patients was compared to healthy controls, correcting for age, and correlated with psychiatric comorbidity.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Bootstrapped quantile regression analysis showed that being a dystonia patient compared to a healthy control significantly explains the methylation level at two CpG sites (CpG 24: pseudo-<jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090.05, <jats:italic>p<\/jats:italic>\u2009=\u20090.04, CpG 32: pseudo-<jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090.14, <jats:italic>p<\/jats:italic>\u2009=\u20090.03). Subgroup analysis revealed that being a DRD patient significantly explained a part of the variance of methylation levels at two CpG sites (CpG 21: pseudo-<jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090.03, <jats:italic>p<\/jats:italic>\u2009=\u20090.00, CpG 24: pseudo-<jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090.06, <jats:italic>p<\/jats:italic>\u2009=\u20090.03). Regression analysis showed that methylation level at CpG 38 significantly explained a small proportion of the variance of severity score for anxiety (<jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090.07, <jats:italic>p<\/jats:italic>\u2009=\u20090.04) and having a diagnosis of depression (Nagelkerke <jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>: 0.11, <jats:italic>p<\/jats:italic>\u2009=\u20090.00). Genotype of the <jats:italic>5-HTTLPR<\/jats:italic> polymorphism had no additional effect on these associations.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study showed an association between percentage of methylation at several specific sites of the promoter region of <jats:italic>SLCA64<\/jats:italic> and (dopa-responsive) dystonia patients compared to healthy controls. Furthermore, methylation levels were associated with severity of anxiety and presence of a depressive disorder in the dystonia group. This study suggests alterations in the serotonergic metabolism in dystonia patients, and its relation with the non-motor symptoms.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13148-022-01384-7","type":"journal-article","created":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T15:02:42Z","timestamp":1670770962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Methylation of the serotonin reuptake transporter gene and non-motor symptoms in dystonia patients"],"prefix":"10.1186","volume":"14","author":[{"given":"Elze R.","family":"Timmers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Pl\u00f6sch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marenka","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid H.","family":"Hof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikst Nynke","family":"Verkaik-Schakel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina A. J.","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom J.","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klary E.","family":"Niezen-Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,11]]},"reference":[{"key":"1384_CR1","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/mds.25475","volume":"28","author":"A Albanese","year":"2013","unstructured":"Albanese A, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013;28:863\u201373. https:\/\/doi.org\/10.1002\/mds.25475.","journal-title":"Mov Disord"},{"key":"1384_CR2","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/mds.23709","volume":"26","author":"DJ Kuyper","year":"2011","unstructured":"Kuyper DJ, Parra V, Aerts S, Okun MS, Kluger BM. Nonmotor manifestations of dystonia: a systematic review. Mov Disord. 2011;26:1206\u201317. https:\/\/doi.org\/10.1002\/mds.23709.","journal-title":"Mov Disord"},{"key":"1384_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","volume":"60","author":"M Berger","year":"2009","unstructured":"Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009;60:355\u201366. https:\/\/doi.org\/10.1146\/annurev.med.60.042307.110802.","journal-title":"Annu Rev Med"},{"key":"1384_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.9758\/cpn.2014.12.3.196","volume":"12","author":"S-H Lin","year":"2014","unstructured":"Lin S-H, Lee L-T, Yang YK. Serotonin and mental disorders: a concise review on molecular neuroimaging evidence. Clin Psychopharmacol Neurosci. 2014;12:196\u2013202. https:\/\/doi.org\/10.9758\/cpn.2014.12.3.196.","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"1384_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neubiorev.2016.03.015","volume":"65","author":"M Smit","year":"2016","unstructured":"Smit M, et al. Serotonergic perturbations in dystonia disorders\u2014a systematic review. Neurosci Biobehav Rev. 2016;65:264\u201375. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.03.015.","journal-title":"Neurosci Biobehav Rev"},{"key":"1384_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.parkreldis.2021.08.019","volume":"91","author":"ER Timmers","year":"2021","unstructured":"Timmers ER, et al. Dopaminergic and serotonergic alterations in plasma in three groups of dystonia patients. Parkinsonism Relat Disord. 2021;91:48\u201354. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.08.019.","journal-title":"Parkinsonism Relat Disord"},{"key":"1384_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10522-012-9406-3","volume":"14","author":"S Fidalgo","year":"2013","unstructured":"Fidalgo S, Ivanov DK, Wood SH. Serotonin: from top to bottom. Biogerontology. 2013;14:21\u201345. https:\/\/doi.org\/10.1007\/s10522-012-9406-3.","journal-title":"Biogerontology"},{"key":"1384_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/107385849800400110","volume":"4","author":"K-P Lesch","year":"1998","unstructured":"Lesch K-P. Review\u202f: serotonin transporter and psychiatric disorders: listening to the gene. Neuroscientist. 1998;4:25\u201334. https:\/\/doi.org\/10.1177\/107385849800400110.","journal-title":"Neuroscientist"},{"key":"1384_CR9","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.pnpbp.2009.08.004","volume":"33","author":"TB Lonsdorf","year":"2009","unstructured":"Lonsdorf TB, et al. The symptomatic profile of panic disorder is shaped by the 5-HTTLPR polymorphism. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:1479\u201383. https:\/\/doi.org\/10.1016\/j.pnpbp.2009.08.004.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1384_CR10","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1126\/science.1083968","volume":"301","author":"A Caspi","year":"2003","unstructured":"Caspi A, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386\u20139. https:\/\/doi.org\/10.1126\/science.1083968.","journal-title":"Science"},{"key":"1384_CR11","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1126\/science.274.5292.1527","volume":"274","author":"K-P Lesch","year":"1996","unstructured":"Lesch K-P, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527\u201331.","journal-title":"Science"},{"key":"1384_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-021-00996-6","author":"A Majumdar","year":"2021","unstructured":"Majumdar A, Patel P, Pasaniuc B, Ophoff RA. A summary-statistics-based approach to examine the role of serotonin transporter promoter tandem repeat polymorphism in psychiatric phenotypes. Eur J Hum Genet. 2021. https:\/\/doi.org\/10.1038\/s41431-021-00996-6.","journal-title":"Eur J Hum Genet"},{"key":"1384_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/mp.2017.44","volume":"23","author":"RC Culverhouse","year":"2018","unstructured":"Culverhouse RC, et al. Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression. Mol Psychiatry. 2018;23:133\u201342. https:\/\/doi.org\/10.1038\/mp.2017.44.","journal-title":"Mol Psychiatry"},{"key":"1384_CR14","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00737-015-0526-z","volume":"18","author":"L Mak","year":"2015","unstructured":"Mak L, Streiner DL, Steiner M. Is serotonin transporter polymorphism (5-HTTLPR) allele status a predictor for obsessive-compulsive disorder? A meta-analysis. Arch Womens Ment Health. 2015;18:435\u201345. https:\/\/doi.org\/10.1007\/s00737-015-0526-z.","journal-title":"Arch Womens Ment Health"},{"key":"1384_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/ajmg.b.30657","volume":"147B","author":"RA Philibert","year":"2008","unstructured":"Philibert RA, et al. The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption Studies. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:543\u20139. https:\/\/doi.org\/10.1002\/ajmg.b.30657.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"1384_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4161\/epi.7.2.18764","volume":"7","author":"EA Mazzio","year":"2012","unstructured":"Mazzio EA, Soliman KFA. Basic concepts of epigenetics: impact of environmental signals on gene expression. Epigenetics. 2012;7:119\u201330. https:\/\/doi.org\/10.4161\/epi.7.2.18764.","journal-title":"Epigenetics"},{"key":"1384_CR17","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/PSY.0b013e3182924cf4","volume":"75","author":"J Zhao","year":"2013","unstructured":"Zhao J, Goldberg J, Bremner JD, Vaccarino V. Association between promoter methylation of serotonin transporter gene and depressive symptoms: a monozygotic twin study. Psychosom Med. 2013;75:523\u20139. https:\/\/doi.org\/10.1097\/PSY.0b013e3182924cf4.","journal-title":"Psychosom Med"},{"key":"1384_CR18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12888-018-1850-4","volume":"18","author":"D Lam","year":"2018","unstructured":"Lam D, et al. Genotype-dependent associations between serotonin transporter gene (SLC6A4) DNA methylation and late-life depression. BMC Psychiatry. 2018;18:282. https:\/\/doi.org\/10.1186\/s12888-018-1850-4.","journal-title":"BMC Psychiatry"},{"key":"1384_CR19","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/da.20825","volume":"28","author":"KC Koenen","year":"2011","unstructured":"Koenen KC, et al. SLC6A4 methylation modifies the effect of the number of traumatic events on risk for posttraumatic stress disorder. Depress Anxiety. 2011;28:639\u201347. https:\/\/doi.org\/10.1002\/da.20825.","journal-title":"Depress Anxiety"},{"key":"1384_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jgg.2012.10.002","volume":"40","author":"H Sugawara","year":"2013","unstructured":"Sugawara H, Bundo M, Ishigooka J, Iwamoto K, Kato T. Epigenetic regulation of serotonin transporter in psychiatric disorders. J Genet Genom. 2013;40:325\u20139. https:\/\/doi.org\/10.1016\/j.jgg.2012.10.002.","journal-title":"J Genet Genom"},{"key":"1384_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.parkreldis.2017.10.005","volume":"45","author":"ER Timmers","year":"2017","unstructured":"Timmers ER, et al. Non-motor symptoms and quality of life in dopa-responsive dystonia patients. Parkinsonism Relat Disord. 2017;45:57\u201362. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.10.005.","journal-title":"Parkinsonism Relat Disord"},{"key":"1384_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.parkreldis.2016.06.004","volume":"30","author":"M Smit","year":"2016","unstructured":"Smit M, et al. Psychiatric co-morbidity is highly prevalent in idiopathic cervical dystonia and significantly influences health-related quality of life: Results of a controlled study. Parkinsonism Relat Disord. 2016;30:7\u201312. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.06.004.","journal-title":"Parkinsonism Relat Disord"},{"key":"1384_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.parkreldis.2019.10.015","volume":"69","author":"ER Timmers","year":"2019","unstructured":"Timmers ER, et al. Myoclonus-dystonia: distinctive motor and non-motor phenotype from other dystonia syndromes. Parkinsonism Relat Disord. 2019;69:85\u201390. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.10.015.","journal-title":"Parkinsonism Relat Disord"},{"key":"1384_CR24","unstructured":"Sheehan DV, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 Suppl 20, 22\u201333;quiz 34\u201357 (1998)."},{"key":"1384_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0272-7358(88)90050-5","volume":"8","author":"AT Beck","year":"1988","unstructured":"Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77\u2013100. https:\/\/doi.org\/10.1016\/0272-7358(88)90050-5.","journal-title":"Clin Psychol Rev"},{"key":"1384_CR26","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1037\/\/0022-006x.56.6.893","volume":"56","author":"AT Beck","year":"1988","unstructured":"Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893\u20137. https:\/\/doi.org\/10.1037\/\/0022-006x.56.6.893.","journal-title":"J Consult Clin Psychol"},{"key":"1384_CR27","doi-asserted-by":"publisher","unstructured":"Goodman WK, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 46, 1006\u20131011. https:\/\/doi.org\/10.1001\/archpsyc.1989.01810110048007 (1989).","DOI":"10.1001\/archpsyc.1989.01810110048007"},{"key":"1384_CR28","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1097\/00004583-199706000-00023","volume":"36","author":"L Scahill","year":"1997","unstructured":"Scahill L, et al. Children\u2019s Yale-Brown obsessive compulsive scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997;36:844\u201352. https:\/\/doi.org\/10.1097\/00004583-199706000-00023.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1384_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4088\/JCP.09m05305whi","volume":"71","author":"DV Sheehan","year":"2010","unstructured":"Sheehan DV, et al. Reliability and validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID). J Clin Psychiatry. 2010;71:313\u201326. https:\/\/doi.org\/10.4088\/JCP.09m05305whi.","journal-title":"J Clin Psychiatry"},{"key":"1384_CR30","first-page":"995","volume":"21","author":"M Kovacs","year":"1985","unstructured":"Kovacs M. The Children\u2019s Depression, Inventory (CDI). Psychopharmacol Bull. 1985;21:995\u20138.","journal-title":"Psychopharmacol Bull"},{"key":"1384_CR31","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/00004583-199704000-00018","volume":"36","author":"B Birmaher","year":"1997","unstructured":"Birmaher B, et al. The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics. J Am Acad Child Adolesc Psychiatry. 1997;36:545\u201353. https:\/\/doi.org\/10.1097\/00004583-199704000-00018.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1384_CR32","doi-asserted-by":"crossref","unstructured":"Riese H, et al. Association between methylation of the SLC6A4 promoter region in peripheral blood leukocytes and methylation in amygdala tissue. Psychosom Med 2014;76.","DOI":"10.1097\/PSY.0000000000000048"},{"key":"1384_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/sj.mp.4000698","volume":"5","author":"M Nakamura","year":"2000","unstructured":"Nakamura M, Ueno S, Sano A, Tanabe H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry. 2000;5:32\u20138. https:\/\/doi.org\/10.1038\/sj.mp.4000698.","journal-title":"Mol Psychiatry"},{"key":"1384_CR34","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3758\/bf03192961","volume":"39","author":"AF Hayes","year":"2007","unstructured":"Hayes AF, Cai L. Using heteroskedasticity-consistent standard error estimators in OLS regression: an introduction and software implementation. Behav Res Methods. 2007;39:709\u201322. https:\/\/doi.org\/10.3758\/bf03192961.","journal-title":"Behav Res Methods"},{"key":"1384_CR35","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1086\/503850","volume":"78","author":"X-Z Hu","year":"2006","unstructured":"Hu X-Z, et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet. 2006;78:815\u201326. https:\/\/doi.org\/10.1086\/503850.","journal-title":"Am J Hum Genet"},{"key":"1384_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.biopsycho.2009.12.003","volume":"83","author":"CA Olsson","year":"2010","unstructured":"Olsson CA, et al. Prospects for epigenetic research within cohort studies of psychological disorder: a pilot investigation of a peripheral cell marker of epigenetic risk for depression. Biol Psychol. 2010;83:159\u201365. https:\/\/doi.org\/10.1016\/j.biopsycho.2009.12.003.","journal-title":"Biol Psychol"},{"key":"1384_CR37","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nrneurol.2015.86","volume":"11","author":"S Wijemanne","year":"2015","unstructured":"Wijemanne S, Jankovic J. Dopa-responsive dystonia\u2013clinical and genetic heterogeneity. Nat Rev Neurol. 2015;11:414\u201324. https:\/\/doi.org\/10.1038\/nrneurol.2015.86.","journal-title":"Nat Rev Neurol"},{"key":"1384_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neubiorev.2016.08.021","volume":"71","author":"L Provenzi","year":"2016","unstructured":"Provenzi L, Giorda R, Beri S, Montirosso R. SLC6A4 methylation as an epigenetic marker of life adversity exposures in humans: a systematic review of literature. Neurosci Biobehav Rev. 2016;71:7\u201320. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.08.021.","journal-title":"Neurosci Biobehav Rev"},{"key":"1384_CR39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13059-016-0926-z","volume":"17","author":"TR Gaunt","year":"2016","unstructured":"Gaunt TR, et al. Systematic identification of genetic influences on methylation across the human life course. Genome Biol. 2016;17:61. https:\/\/doi.org\/10.1186\/s13059-016-0926-z.","journal-title":"Genome Biol"},{"key":"1384_CR40","doi-asserted-by":"publisher","unstructured":"Alameda L, et al. Can epigenetics shine a light on the biological pathways underlying major mental disorders? Psychol Med. https:\/\/doi.org\/10.1017\/S0033291721005559 (2022).","DOI":"10.1017\/S0033291721005559"},{"key":"1384_CR41","doi-asserted-by":"publisher","first-page":"e1167","DOI":"10.1038\/tp.2017.133","volume":"7","author":"M Drabe","year":"2017","unstructured":"Drabe M, et al. Serotonin transporter gene promoter methylation status correlates with in vivo prefrontal 5-HTT availability and reward function in human obesity. Transl Psychiatry. 2017;7:e1167\u2013e1167. https:\/\/doi.org\/10.1038\/tp.2017.133.","journal-title":"Transl Psychiatry"},{"key":"1384_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039501","volume":"7","author":"D Wang","year":"2012","unstructured":"Wang D, et al. Peripheral SLC6A4 DNA methylation is associated with in vivo measures of human brain serotonin synthesis and childhood physical aggression. PLoS ONE. 2012;7: e39501. https:\/\/doi.org\/10.1371\/journal.pone.0039501.","journal-title":"PLoS ONE"},{"key":"1384_CR43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41398-018-0195-6","volume":"8","author":"E Ismaylova","year":"2018","unstructured":"Ismaylova E, et al. Serotonin transporter promoter methylation in peripheral cells and neural responses to negative stimuli: a study of adolescent monozygotic twins. Transl Psychiatry. 2018;8:147. https:\/\/doi.org\/10.1038\/s41398-018-0195-6.","journal-title":"Transl Psychiatry"},{"key":"1384_CR44","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.euroneuro.2019.07.131","volume":"29","author":"MA Schiele","year":"2019","unstructured":"Schiele MA, et al. Hypermethylation of the serotonin transporter gene promoter in panic disorder\u2014Epigenetic imprint of comorbid depression? Eur Neuropsychopharmacol. 2019;29:1161\u20137. https:\/\/doi.org\/10.1016\/j.euroneuro.2019.07.131.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1384_CR45","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.jpsychires.2013.04.010","volume":"47","author":"JM Kim","year":"2013","unstructured":"Kim JM, et al. A longitudinal study of SLC6A4 DNA promoter methylation and poststroke depression. J Psychiatr Res. 2013;47:1222\u20137. https:\/\/doi.org\/10.1016\/j.jpsychires.2013.04.010.","journal-title":"J Psychiatr Res"},{"key":"1384_CR46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/hup.2527","volume":"31","author":"J Iga","year":"2016","unstructured":"Iga J, et al. Association study of polymorphism in the serotonin transporter gene promoter, methylation profiles, and expression in patients with major depressive disorder. Hum Psychopharmacol. 2016;31:193\u20139. https:\/\/doi.org\/10.1002\/hup.2527.","journal-title":"Hum Psychopharmacol"},{"key":"1384_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jpsychires.2014.02.002","volume":"53","author":"S Okada","year":"2014","unstructured":"Okada S, et al. The potential of SLC6A4 gene methylation analysis for the diagnosis and treatment of major depression. J Psychiatr Res. 2014;53:47\u201353. https:\/\/doi.org\/10.1016\/j.jpsychires.2014.02.002.","journal-title":"J Psychiatr Res"},{"key":"1384_CR48","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.biopsycho.2013.10.006","volume":"96","author":"SRH Beach","year":"2014","unstructured":"Beach SRH, Dogan MV, Brody GH, Philibert RA. Differential impact of cumulative SES risk on methylation of protein\u2013protein interaction pathways as a function of SLC6A4 genetic variation in African American young adults. Biol Psychol. 2014;96:28\u201334. https:\/\/doi.org\/10.1016\/j.biopsycho.2013.10.006.","journal-title":"Biol Psychol"},{"key":"1384_CR49","doi-asserted-by":"publisher","first-page":"e0119061","DOI":"10.1371\/journal.pone.0119061","volume":"10","author":"L Booij","year":"2015","unstructured":"Booij L, et al. DNA methylation of the serotonin transporter gene in peripheral cells and stress-related changes in hippocampal volume: a study in depressed patients and healthy controls. PLoS ONE. 2015;10:e0119061\u2013e0119061. https:\/\/doi.org\/10.1371\/journal.pone.0119061.","journal-title":"PLoS ONE"},{"key":"1384_CR50","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12888-021-03166-6","volume":"21","author":"S Sanwald","year":"2021","unstructured":"Sanwald S, et al. Factors related to age at depression onset: the role of SLC6A4 methylation, sex, exposure to stressful life events and personality in a sample of inpatients suffering from major depression. BMC Psychiatry. 2021;21:167. https:\/\/doi.org\/10.1186\/s12888-021-03166-6.","journal-title":"BMC Psychiatry"},{"key":"1384_CR51","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/brain\/awab360","volume":"145","author":"N Mirza-Schreiber","year":"2021","unstructured":"Mirza-Schreiber N, et al. Blood DNA methylation provides an accurate biomarker of KMT2B-related dystonia and predicts onset. Brain. 2021;145:644\u201354. https:\/\/doi.org\/10.1093\/brain\/awab360.","journal-title":"Brain"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-022-01384-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-022-01384-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-022-01384-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T19:03:25Z","timestamp":1671044605000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-022-01384-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1384"],"URL":"https:\/\/doi.org\/10.1186\/s13148-022-01384-7","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"19 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all participants, and the study was approved by the medical ethics committee of the University Medical Center Groningen (METc 2014\/034).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"170"}}